The report describes the 340B Drug Pricing Program, which certain health care providers to receive significant discounts on certain prescription medications, including HIV medications. The report includes key 340B policies, as well as recent utilization trends and challenges.
Overview of the 340B Drug Pricing Program
Medicare Payment Advisory Commission (MedPAC)
Browse for More
Total views: 364